HCW Biologics Cash Flow Statement 2020-2025 | HCWB

Net Income/Loss

$-24.994

$-14.901

$-12.863

$-5.802

Total Depreciation And Amortization - Cash Flow

$1.135

$0.718

$0.544

$0.573

Other Non-Cash Items

$0.738

$1.309

$-0.112

$0.045

Total Non-Cash Items

$1.873

$2.027

$0.431

$0.618

Change In Accounts Receivable

$-1.118

$-0.285

$2.367

$-2.5

Change In Inventories

Change In Accounts Payable

Change In Assets/Liabilities

$0.106

$2.355

$-2.799

$-2.118

Total Change In Assets/Liabilities

$0.607

$2.488

$1.455

$-5.247

Cash Flow From Operating Activities

$-22.514

$-10.386

$-10.976

$-10.431

Net Change In Property, Plant, And Equipment

$-6.203

$-10.275

$-0.047

$-0.187

Net Change In Intangible Assets

Net Acquisitions/Divestitures

Net Change In Short-term Investments

$10

$24.984

$-24.987

Net Change In Long-Term Investments

$-9.984

Net Change In Investments - Total

$10

$24.984

$-34.972

Investing Activities - Other

Cash Flow From Investing Activities

$3.797

$14.708

$-35.019

$-0.187

Net Long-Term Debt

$-0.038

$6.448

$0.564

Net Current Debt

Debt Issuance/Retirement Net - Total

$-0.038

$6.448

$0.564

Net Common Equity Issued/Repurchased

$0.024

$0.016

$0.03

$0.01

Net Total Equity Issued/Repurchased

$0.024

$0.016

$0.03

$11.154

Total Common And Preferred Stock Dividends Paid

Financial Activities - Other

$-0.191

$49.24

Cash Flow From Financial Activities

$-0.015

$6.273

$49.27

$11.718

Net Cash Flow

$-18.731

$10.596

$3.275

$1.1

Stock-Based Compensation

$1.004

$1.12

$0.361

$0.022

Common Stock Dividends Paid